Fig. 1 · Structure

Documents & Downloads

Paxalisib (GDC-0084)

Cat. No. A16272 CAS 1382979-44-3

PI3K inhibitor

GDC-0084 is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
PI3Kα Ki 2 nM

Cellular Effect

Cell Line Activity Value Description Reference
PC-3 EC50 0.4 μM Antiproliferative activity against human PC3 cells after 3 days by CellTitre-Glo assay [PMID: 27096040]
SF-268 EC50 1.01 μM Antiproliferative activity against human SF268 cells after 4 days by CellTitre-Glo assay [PMID: 27096040]
U-87MG ATCC EC50 0.74 μM Antiproliferative activity against human U87 cells after 4 days by CellTitre-Glo assay [PMID: 27096040]

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1382979-44-3
Applications PI3K inhibitor
Formula C18H22N8O2
Molecular Weight 382.428
Synonyms RG7666; GDC-0084
SMILES
NC1=NC=C(C2=NC(N3CCOCC3)=C4N=C(C(C)(C)OCC5)N5C4=N2)C=N1

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 8 mg/mL (20.91 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...